TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Equillium, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-19 06:03 am Purchase | 2023-12-31 | 13G | Equillium, Inc. EQ | TAKEDA PHARMACEUTICAL CO LTD | 1,842,977 5.200% | 1,842,977 (New Position) | Filing |